Given the importance of the granulocyte-macrophage colony-stimulating factor (GM-CSF) in the simulation of CRS, some studies have focused on the attenuation of its effect on the CRS induction upon CAR-T cell therapy. This evidence concerns the gene CSF2 and congenital rubella syndrome.